Categories: Health

Allianz Partners appoints Okan zdemir as its new Chief Officer for Health

NEW DELHI and PARIS, Sept. 10, 2025 /PRNewswire/ — Allianz Partners, a global leader in insurance and assistance services, is pleased to announce the appointment of Okan Özdemir as its new Chief Officer for Health and Board Member, effective September 1, 2025. In this role, Okan will report directly to Allianz Partners CEO Tomas Kunzmann

- Advertisement -

Okan Özdemir joins Allianz Partners from Allianz Türkiye, where he served as Chief Health Officer and Executive Board Member since 2019. With over 24 years of strong leadership at Allianz in a number of strategic roles including Chief Marketing Officer, he has been instrumental in advancing the company’s market leadership and growth in health insurance while overseeing a significant digital transformation within the business. 

- Advertisement -

Okan holds a degree in Business Administration from Istanbul University and a Master’s degree in Business from the European School of Management and Technology.

In his new global position, Okan will continue to strengthen Allianz Partners’ health line of business and health portfolio worldwide, while expanding its market leadership in the global health segment. 

- Advertisement -

Okan Özdemir will succeed Ida Luka-Lognoné, who has led the Health business since 2015, overseeing significant growth and expansion, including developing new customer segments and expanding global operations. Ida has had a successful career spanning 30 years at Allianz Group, the last ten years of which at Allianz Partners where she played a key role in transforming the Health business into a global leader in innovative health solutions. Her leadership was instrumental in creating a culture of customer-centricity and driving strategic initiatives that positioned Allianz Partners at the forefront of the industry. 

- Advertisement -

Tomas Kunzmann, CEO of Allianz Partners, commented: “We are pleased to welcome Okan as our new Chief Officer for Health, following Ida Luka-Lognoné who has made a lasting impact on our organization. Okan’s deep know-how in Health as well as his experience in digital transformation will serve well in further expansion of the Health business and it reflects Allianz Partners’ strong momentum and our ambition to double revenues by 2030. Health remains a critical pillar of our growth strategy, and I am confident that under his leadership, we will continue to introduce innovative solutions that deliver value and peace of mind to millions of customers worldwide.” 

About Allianz Partners  

- Advertisement -

Allianz Partners is a world leader in B2B2C insurance and assistance, offering global solutions that span travel insurance, mobility, assistance, health insurance and employee benefits. Customer driven, our innovative experts are redefining insurance services by delivering future-ready, high-tech high-touch products and solutions that go beyond traditional insurance. Our products are embedded seamlessly into our partners’ businesses, sold through intermediary channels or directly to customers through the Allianz brand. Present in over 73 countries, our 22,600 employees speak 70 languages, handle over 95 million cases each year, and are motivated to go the extra mile to offer peace of mind to our customers around the world.  

- Advertisement -

For more information, please visit: www.allianz-partners.com 

Social media  

- Advertisement -

Follow us on X @AllianzPartners 

- Advertisement -

Follow us on LinkedIn Allianz Partners 

Follow us on YouTube /allianzpartners 

- Advertisement -

Follow us on Instagram @allianzpartners 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2769722/Okan__zdemir__Chief_Officer_for_Health__Allianz_Partners.jpg
Logo – https://mma.prnewswire.com/media/2661649/AZ_Partners_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/allianz-partners-appoints-okan-ozdemir-as-its-new-chief-officer-for-health-302551969.html

- Advertisement -
PRNW Agency

Recent Posts

NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimers Disease Program

The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to start the IND-enabling…

46 minutes ago

KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025

RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research…

46 minutes ago

MG 3 receives four stars but suffers rare and serious seat failure in Euro NCAP crash test

LEUVEN, BELGIUM – For decades, MG’s catchy slogan was ‘Safety Fast’ as the British marque…

47 minutes ago

Ten athlete ambassadors engaged in preventing competition manipulation announced

10 September 2025 – Ten athletes from every continent and 10 different sports have been…

50 minutes ago

adidas and the Future Audi F1 Team Announce MultiYear Partnership

adidas will be an Official Team Partner, bringing innovative product to technical team and fanwear…

50 minutes ago

2025 Chinese Opera (Kunshan) Festival Opens, Celebrating the Vitality of Traditional Chinese Opera

KUNSHAN, China, Sept. 10, 2025 /PRNewswire/ -- The 2025 Chinese Opera (Kunshan) Festival, co-organized by…

51 minutes ago